Who is sponsoring NCT05089864?

NCT05089864 is sponsored by Saint Luke's Health System.

What drugs are being tested in NCT05089864?

Interventions in NCT05089864: Stent Placement Timing - Early, Stent Placement Timing - Late.

What condition does NCT05089864 study?

NCT05089864 studies Coronary Occlusion, Coronary Stenosis, Coronary Restenosis.

Is NCT05089864 still recruiting?

NCT05089864 is currently completed. Last updated 24 October 2025.

Last reviewed 2025-10-24 · How we verify

NCT05089864: STAR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

STAR and Deferred Stenting Study

Completed NA Last updated 24 October 2025

What this trial tests

NA trial testing Stent Placement Timing - Early in Coronary Occlusion in 150 participants. Completed in 7 August 2025.

Timeline

23 November 2021

Primary endpoint
7 August 2025

7 August 2025

Quick facts

Lead sponsor	Saint Luke's Health System
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	150
Start date	23 November 2021
Primary completion	7 August 2025
Estimated completion	7 August 2025
Sites	1 location across United States

Drugs / interventions tested

Stent Placement Timing - Early
Stent Placement Timing - Late

Conditions studied

Coronary Occlusion — all drugs for Coronary Occlusion →
Coronary Stenosis — all drugs for Coronary Stenosis →
Coronary Restenosis — all drugs for Coronary Restenosis →

Sponsor

Saint Luke's Health System — full company profile →

Who can join

18 and older, any sex, with Coronary Occlusion or Coronary Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

STAR is a minimal-risk pragmatic clinical trial of patients admitted for a CTO-PCI procedure. The overall objective of the STAR Study is to address the current gaps in knowledge regarding use of STAR during CTO-PCI, as a prospective, multi-center study of 150 participants with randomization of timing of staged PCI. Five sites will be selected to participate in STAR from a national network of highly experienced CTO-PCI centers across the United States.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Optimal timing of staged percutaneous coronary intervention after subintimal tracking and re-entry: Rationale and design of the subintimal tracking and re-entry with deferred stenting study.
Hirai T, Kearney K, Azzalini L, Salisbury AC, et al · · 2024 · cited 5× · PMID 39044659 · DOI 10.1002/ccd.31161
Early vs Late Staged PCI After Subintimal Tracking and Re-Entry for Chronic Total Occlusions: A Randomized Trial.
Azzalini L, Kearney K, Salisbury AC, Stone N, et al · · 2026 · cited 4× · PMID 41295935 · DOI 10.1016/j.jacc.2025.09.1598
Use of Subintimal Tracking and Re-entry Technique as a Bailout After Coronary Dissection.
Hirai T, Mansour A, Grantham JA, Spaedy A. · · 2022 · cited 1× · PMID 39131938 · DOI 10.1016/j.jscai.2022.100348

Verify or expand the search:

Other recruiting trials for Coronary Occlusion

Currently open trials in the same condition.

NCT06878729 — Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI · NA · recruiting
NCT06528821 — AI-Powered ECG Detecting Culprit Vessel Blood Flow Abnormality in ACS · active not recruiting
NCT06542393 — PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG) · Phase 2 · recruiting
NCT06681584 — Comparison of the Diagnostic Performance and Costs of FFRB Vs. Standard Care in Suspected Coronary Artery Disease. · active not recruiting
NCT04604197 — ANGiographic Evaluation of Left Main Coronary Artery INtErvention · NA · active not recruiting

Other Saint Luke's Health System trials

Trials by the same sponsor.

NCT06969365 — Weighted Blankets for IUD Insertion · Phase 1 · enrolling by invitation
NCT05900362 — Feasibility and Success Trial of Remote Patient Monitoring in Heart Failure · NA · not yet recruiting
NCT05093764 — Quantification of Debris Captured Using TCEP During VIV TAVR With BVF · NA · recruiting
NCT03664466 — Astaxanthin Effects on Osteoarthritis Associated Pain and Inflammatory Indicators · NA · withdrawn
NCT05229926 — Implementation of CareCube Negative Pressure Isolation Units · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05089864 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saint Luke's Health System
Last refreshed: 24 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05089864.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing